Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Pain 5Neoplasms 3Colorectal Neoplasms 3Adenoma 3Stomatitis 2Stomach Neoplasms 2Insulin Resistance 2Breast Neoplasms 2Vulvodynia 1Urologic Neoplasms 1Urolithiasis 1Thyroid Neoplasms 1Sleep Initiation and Maintenance Disorders 1Skin Neoplasms 1Polycystic Ovary Syndrome 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Mobility Limitation 1Melanoma 1MRSA Colonization 1Lymphoma 1Leukemia 1Ilues 1Hypothyroidism 1Hydronephrosis 1Hematologic Diseases 1Head and Neck Neoplasms 1Fatigue 1Fasting 1

Interventions

Nivolumab 146Ipilimumab 137pembrolizumab 122Cyclophosphamide 78Interleukin-2 69aldesleukin 63Temozolomide 46trametinib 37Radiosurgery 37Vemurafenib 36fludarabine 34Biopsy 34dabrafenib 33Radiotherapy 33Blood Specimen Collection 31fludarabine phosphate 30sargramostim 27Bevacizumab 27Introns 23Dacarbazine 22Magnetic Resonance Spectroscopy 21Specimen Handling 20CTLA-4 Antigen 20encorafenib 19cobimetinib 19binimetinib 19Paclitaxel 19Granulocyte-Macrophage Colony-Stimulating Factor 19Cisplatin 17incomplete Freund's adjuvant 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Melanoma × Water × Clear all
NCT05854589 2023-05-11

Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.

Batroussy, Rafik

Phase 2 Unknown
20 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡